168 related articles for article (PubMed ID: 32617308)
1. Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma.
Sui X; Zhang C; Jiang Y; Zhou J; Xu C; Tang F; Chen B; Xu H; Wang S; Wang X
Ann Transl Med; 2020 Jun; 8(11):688. PubMed ID: 32617308
[TBL] [Abstract][Full Text] [Related]
2. Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime.
Zhang C; Xu H; Sui X; Chen L; Chen B; Lv H; Wang S; Wang X
Mol Ther Oncolytics; 2022 Jun; 25():288-304. PubMed ID: 35663228
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
Sui X; Zhang C; Zhou J; Cao S; Xu C; Tang F; Zhi X; Chen B; Wang S; Yin L
J Exp Clin Cancer Res; 2017 Sep; 36(1):133. PubMed ID: 28950914
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway.
Zhou J; Zhang C; Sui X; Cao S; Tang F; Sun S; Wang S; Chen B
Invest New Drugs; 2018 Aug; 36(4):571-580. PubMed ID: 29504068
[TBL] [Abstract][Full Text] [Related]
5. The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphoma.
Gao Y; Feng X; Song W; Li H; Shi C; Jin M; Li Z; Zhang L; Zhang M
Hematol Oncol; 2022 Oct; 40(4):678-688. PubMed ID: 35439335
[TBL] [Abstract][Full Text] [Related]
6. The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma.
Zhang Z; Liu E; Zhang D; Zhao W; Wang G; Zhang Y; Huo Y; Zhang C; Li W
Diagn Pathol; 2023 Nov; 18(1):129. PubMed ID: 38037110
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor receptor alpha (PDGFRα) is overexpressed in NK/T-cell lymphoma and mediates cell survival.
Lu L; Fu X; Li Z; Qiu Y; Li W; Zhou Z; Xue W; Wang Y; Jin M; Zhang M
Biochem Biophys Res Commun; 2018 Oct; 504(2):525-531. PubMed ID: 30201265
[TBL] [Abstract][Full Text] [Related]
8. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
[TBL] [Abstract][Full Text] [Related]
9. Suppression of latent transforming growth factor-β (TGF-β)-binding protein 1 (LTBP1) inhibits natural killer/ T cell lymphoma progression by inactivating the TGF-β/Smad and p38
Lin R; Li X; Wu S; Qian S; Hou H; Dong M; Zhang X; Zhang M
Exp Cell Res; 2021 Oct; 407(1):112790. PubMed ID: 34418460
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of sonic hedgehog signaling blocks cell migration and growth but induces apoptosis via suppression of FOXQ1 in natural killer/T-cell lymphoma.
Liu P; Chen L
Leuk Res; 2018 Jan; 64():1-9. PubMed ID: 29132010
[TBL] [Abstract][Full Text] [Related]
12.
Xu B; Jiang L; Cui JL; Zhu XL; Bai YJ; Chen J; Diao YQ
Ann Transl Med; 2022 Dec; 10(23):1276. PubMed ID: 36618816
[TBL] [Abstract][Full Text] [Related]
13. Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.
Qing M; Zhou T; Perova T; Abraham Y; Sweeney C; Krevvata M; Zhang X; Qi M; Gao G; Kim TM; Yao M; Cho SG; Eom HS; Lim ST; Yeh SP; Kwong YL; Yoon DH; Kim JS; Kim WS; Zhou L; Attar R; Verona RI
Ann Hematol; 2024 Jun; 103(6):1989-2001. PubMed ID: 38233570
[TBL] [Abstract][Full Text] [Related]
14. PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphoma.
Wu J; Shi C; Li H; Song W; Huang S; Zhang J; Li W; Li Z; Zhang M
BMC Med; 2023 Jul; 21(1):253. PubMed ID: 37442994
[TBL] [Abstract][Full Text] [Related]
15. Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.
Chen YW; Guo T; Shen L; Wong KY; Tao Q; Choi WW; Au-Yeung RK; Chan YP; Wong ML; Tang JC; Liu WP; Li GD; Shimizu N; Loong F; Tse E; Kwong YL; Srivastava G
Blood; 2015 Mar; 125(10):1589-600. PubMed ID: 25612622
[TBL] [Abstract][Full Text] [Related]
16. Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphoma.
Zhang P; Shi C; Song Y; Li Z; Zhang M; Jin M
Hematol Oncol; 2022 Dec; 40(5):941-952. PubMed ID: 35797410
[TBL] [Abstract][Full Text] [Related]
17. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
Ma H; Shen L; Yang H; Gong H; Du X; Li J
IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
[TBL] [Abstract][Full Text] [Related]
18. Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice.
Li Z; Liu J; Li J; Kong Y; Sandusky G; Rao X; Liu Y; Wan J; Liu X
J Biol Chem; 2017 Oct; 292(42):17461-17472. PubMed ID: 28900036
[TBL] [Abstract][Full Text] [Related]
19. IL-13 and IL-13Rα1 are overexpressed in extranodal natural killer/T cell lymphoma and mediate tumor cell proliferation.
Zhang Y; Li C; Zhang M; Li Z
Biochem Biophys Res Commun; 2018 Sep; 503(4):2715-2720. PubMed ID: 30107911
[TBL] [Abstract][Full Text] [Related]
20. IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma.
Wang L; Bi XW; Zhu YJ; He YZ; Lai QY; Xia ZJ; Cai QQ
Cancer Commun (Lond); 2018 Oct; 38(1):62. PubMed ID: 30340635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
